Clinical Trials Sponsored by Lorus Therapeutics
Total 6332 results
-
Sage TherapeuticsRecruitingHuntington's DiseaseUnited States, Australia, Canada, United Kingdom
-
Protara TherapeuticsRecruitingNon-muscle Invasive Bladder CancerUnited States
-
Faeth TherapeuticsRecruitingMetastatic Pancreatic Adenocarcinoma | Locally Advanced Unresectable Pancreatic AdenocarcinomaUnited States
-
Aerovate TherapeuticsRecruitingPulmonary Arterial HypertensionUnited States, Belgium, Italy, Spain, Australia, Canada, China, Poland, Singapore, Argentina, United Kingdom, France, Israel, Latvia, Austria, Mexico, Puerto Rico, Sweden, South Africa, Netherlands, Chile, Germany, Greece, Portugal, Cze... and more
-
Allogene TherapeuticsRecruitingAdvanced/Metastatic Clear Cell Renal Cell CarcinomaUnited States
-
LIDDE TherapeuticsRecruitingHemorrhagic CystitisFrance
-
Harpoon TherapeuticsRecruitingSmall-cell Lung CancerUnited States
-
Allogene TherapeuticsRecruitingRelapsed or Refractory Large B Cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small Lymphocytic LymphomaUnited States, Spain, Canada, Australia, Italy
-
Tiburio TherapeuticsNot yet recruitingNon-Functional Pituitary Adenoma | Pituitary Tumor, Nonfunctioning
-
Corcept TherapeuticsRecruitingHypercortisolismUnited States, Austria, Bulgaria, Germany, Israel, Italy, Poland, Romania, Spain
-
Akcea TherapeuticsRecruitingHereditary Transthyretin Amyloidosis With PolyneuropthyUnited States, Canada
-
BioEclipse TherapeuticsRecruitingHepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Osteosarcoma | Triple Negative Breast Cancer | Epithelial Ovarian Cancer | Non-small Cell Lung Cancer | Solid Tumor, Adult | Malignant MelanomaUnited States
-
Amicus TherapeuticsRecruiting
-
Aspa TherapeuticsRecruiting
-
Effector TherapeuticsRecruitingSolid Tumor, AdultUnited States
-
Amicus TherapeuticsRecruitingPompe Disease (Late-onset)United States, Taiwan, Japan, Australia, Canada
-
PTC TherapeuticsActive, not recruitingFriedreich AtaxiaUnited States
-
Intellia TherapeuticsEnrolling by invitationHereditary AngioedemaFrance, New Zealand, United Kingdom, Netherlands
-
Sage TherapeuticsCompletedHuntington DiseaseUnited States
-
PTC TherapeuticsActive, not recruitingAADC DeficiencyUnited States, Israel, Taiwan
-
OrphAI TherapeuticsCompletedAcute Myeloid Leukemia | OncologyUnited States
-
Sangamo TherapeuticsActive, not recruitingHemophilia B | Mucopolysaccharidosis I | Mucopolysaccharidosis IIUnited States
-
Corcept TherapeuticsActive, not recruitingAmyotrophic Lateral SclerosisUnited States, Belgium, Canada, France, Germany, Ireland, Netherlands, Poland, Spain, United Kingdom
-
Aprea TherapeuticsCompletedAcute Myeloid Leukemia or Myelodysplastic SyndromesUnited States
-
PTC TherapeuticsEnrolling by invitationDuchenne Muscular DystrophyUnited States, Canada
-
PTC TherapeuticsEnrolling by invitationFriedreich AtaxiaUnited States, Australia, Brazil, Canada, France, Germany, Italy, New Zealand, Spain
-
Geneos TherapeuticsActive, not recruitingHCCUnited States, New Zealand
-
Chelsea TherapeuticsCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Sage TherapeuticsCompletedEssential TremorUnited States
-
Northern TherapeuticsTerminated
-
UNION therapeuticsCompletedSkin Diseases | PsoriasisUnited Kingdom, Poland, United States, Germany
-
Transcend TherapeuticsEnrolling by invitationPost Traumatic Stress DisorderUnited Kingdom
-
PTC TherapeuticsCompletedFriedreich AtaxiaUnited States, Australia, Brazil, Canada, France, Germany, Italy, New Zealand, Spain
-
Amicus TherapeuticsActive, not recruitingPompe Disease (Late-onset)United States, Germany, Taiwan, Belgium, Australia, Slovenia, Spain, Netherlands, Hungary, Japan, Austria, United Kingdom, France, Argentina, Canada, Sweden, Denmark, New Zealand, Greece, Korea, Republic of, Bosnia and Herzegovina, Ita... and more
-
Aligos TherapeuticsTerminatedChronic Hepatitis BNew Zealand, Bulgaria, Moldova, Republic of, Romania
-
PTC TherapeuticsCompletedLeiomyosarcomaUnited States
-
Fulcrum TherapeuticsTerminated
-
Nektar TherapeuticsCompletedCovid-19 | Coronavirus Disease 2019United States
-
Repare TherapeuticsActive, not recruitingAdvanced Solid TumorUnited States, Canada, Spain, United Kingdom
-
Spero TherapeuticsCompleted
-
Aprea TherapeuticsCompletedPlatinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53United States, France, Spain, Netherlands, United Kingdom, Belgium, Germany, Sweden
-
Aprea TherapeuticsCompletedHigh-grade Serous Ovarian CancerSpain, United Kingdom, Belgium
-
Lykos TherapeuticsNo longer availablePost Traumatic Stress DisorderUnited States
-
ONL TherapeuticsCompletedRhegmatogenous Retinal Detachment - Macula OffUnited States
-
Guided TherapeuticsEnrolling by invitationCervical DysplasiaUnited States
-
Harpoon TherapeuticsTerminatedAdvanced Prostate CancerUnited States, United Kingdom
-
Chelsea TherapeuticsCompletedNeurogenic Orthostatic Hypotension | Primary Autonomic Failure | Dopamine Beta Hydroxylase Deficiency | Non-Diabetic Neuropathy
-
Repare TherapeuticsActive, not recruitingAdult Solid TumorUnited States, Canada, United Kingdom
-
Lykos TherapeuticsTerminatedPosttraumatic Stress DisorderCanada